Capital Counsel LLC Idexx Laboratories Inc Transaction History

Capital Counsel LLC

$2.32 Billion
Q3 2024

A detailed history of Capital Counsel LLC transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Capital Counsel LLC holds 471,179 shares of IDXX stock, worth $197 Million. This represents 10.24% of its overall portfolio holdings.

Number of Shares

471,179

Previous 470,099 0.23%

Holding current value

$197 Million

Previous $229 Million 3.9%

% of portfolio

10.24%

Previous 10.23%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$455.08 - $517.19 $491,486 - $558,565	1,080 Added 0.23%	471,179 $238 Million
Q2 2024 Aug 14, 2024	BUY	$468.04 - $548.53 $254,613 - $298,400	544 Added 0.12%	470,099 $229 Million
Q1 2024 May 15, 2024	SELL	$515.08 - $576.87 $177,702 - $199,020	-345 Reduced 0.07%	469,555 $254 Million
Q4 2023 Feb 14, 2024	SELL	$391.37 - $557.56 $927,546 - $1.32 Million	-2,370 Reduced 0.5%	469,900 $261 Million
Q3 2023 Nov 13, 2023	SELL	$432.42 - $556.67 $314,369 - $404,699	-727 Reduced 0.15%	472,270 $207 Million
Q2 2023 Aug 14, 2023	SELL	$450.7 - $503.61 $1.59 Million - $1.77 Million	-3,524 Reduced 0.74%	472,997 $238 Million
Q1 2023 May 15, 2023	SELL	$406.01 - $514.59 $5.82 Million - $7.38 Million	-14,345 Reduced 2.92%	476,521 $238 Million
Q4 2022 Feb 09, 2023	BUY	$324.64 - $441.27 $530,461 - $721,035	1,634 Added 0.33%	490,866 $200 Million
Q3 2022 Nov 14, 2022	BUY	$325.8 - $407.78 $1.11 Million - $1.39 Million	3,416 Added 0.7%	489,232 $159 Million
Q2 2022 Aug 15, 2022	BUY	$327.37 - $553.44 $4.28 Million - $7.23 Million	13,064 Added 2.76%	485,816 $170 Million
Q1 2022 May 16, 2022	BUY	$466.52 - $631.01 $44,785 - $60,576	96 Added 0.02%	472,752 $259 Million
Q4 2021 Feb 14, 2022	BUY	$586.54 - $666.48 $553,693 - $629,157	944 Added 0.2%	472,656 $311 Million
Q3 2021 Nov 12, 2021	SELL	$621.9 - $705.76 $22.9 Million - $26 Million	-36,769 Reduced 7.23%	471,712 $293 Million
Q2 2021 Aug 12, 2021	SELL	$486.36 - $637.08 $3.88 Million - $5.09 Million	-7,984 Reduced 1.55%	508,481 $321 Million
Q1 2021 May 12, 2021	SELL	$465.18 - $551.79 $9.49 Million - $11.3 Million	-20,400 Reduced 3.8%	516,465 $253 Million
Q4 2020 Feb 10, 2021	SELL	$383.85 - $499.87 $3.98 Million - $5.19 Million	-10,378 Reduced 1.9%	536,865 $268 Million
Q3 2020 Nov 16, 2020	SELL	$334.54 - $406.31 $22.7 Million - $27.6 Million	-67,806 Reduced 11.02%	547,243 $215 Million
Q2 2020 Aug 14, 2020	SELL	$230.66 - $330.16 $7.01 Million - $10 Million	-30,389 Reduced 4.71%	615,049 $203 Million
Q1 2020 May 15, 2020	SELL	$182.94 - $290.97 $5.07 Million - $8.06 Million	-27,707 Reduced 4.12%	645,438 $156 Million
Q4 2019 Feb 14, 2020	SELL	$248.66 - $285.01 $5.25 Million - $6.02 Million	-21,112 Reduced 3.04%	673,145 $176 Million
Q3 2019 Nov 14, 2019	BUY	$260.07 - $289.93 $1.73 Million - $1.93 Million	6,641 Added 0.97%	694,257 $189 Million
Q2 2019 Aug 14, 2019	BUY	$215.53 - $275.33 $371,573 - $474,668	1,724 Added 0.25%	687,616 $189 Million
Q1 2019 May 15, 2019	BUY	$178.02 - $225.69 $586,041 - $742,971	3,292 Added 0.48%	685,892 $153 Million
Q4 2018 Feb 13, 2019	SELL	$176.18 - $248.92 $555,847 - $785,342	-3,155 Reduced 0.46%	682,600 $127 Million
Q3 2018 Nov 14, 2018	SELL	$218.82 - $254.46 $9.06 Million - $10.5 Million	-41,402 Reduced 5.69%	685,755 $171 Million
Q2 2018 Aug 14, 2018	SELL	$185.56 - $227.9 $2.48 Million - $3.04 Million	-13,347 Reduced 1.8%	727,157 $158 Million
Q1 2018 May 14, 2018	SELL	$157.81 - $204.73 $351,127 - $455,524	-2,225 Reduced 0.3%	740,504 $142 Million
Q4 2017 Feb 13, 2018	BUY	$147.68 - $168.37 $1.43 Million - $1.63 Million	9,666 Added 1.32%	742,729 $116 Million
Q3 2017 Nov 14, 2017	BUY	$150.32 - $166.46 $110 Million - $122 Million	733,063	733,063 $114 Million

Others Institutions Holding IDXX

# of Institutions

1,212

Shares Held

72.6M

Call Options Held

167K

Put Options Held

343K

View Full List

About IDEXX LABORATORIES INC

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $34.7B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

More about IDXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Counsel LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Counsel LLC with notifications on news.

Account

Capital Counsel LLC Idexx Laboratories Inc Transaction History